Symbols / NDRA
NDRA Chart
About
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Diagnostics & Research | Market Cap | 5.78M |
| Enterprise Value | 4.11M | Income | -8.01M | Sales | — |
| Book/sh | 0.22 | Cash/sh | 0.68 | Dividend Yield | — |
| Payout | 0.00% | Employees | 21 | IPO | — |
| P/E | 0.20 | Forward P/E | -0.84 | PEG | — |
| P/S | — | P/B | 17.71 | P/C | — |
| EV/EBITDA | -0.49 | EV/Sales | — | Quick Ratio | 0.99 |
| Current Ratio | 1.31 | Debt/Eq | 306.53 | LT Debt/Eq | — |
| EPS (ttm) | 19.62 | EPS next Y | -4.62 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-11-14 16:00 | ROA | -101.97% |
| ROE | -236.34% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 1.50M |
| Shs Float | 1.10M | Short Float | 4.22% | Short Ratio | 2.02 |
| Short Interest | — | 52W High | 11.96 | 52W Low | 2.90 |
| Beta | -0.04 | Avg Volume | 50.92K | Volume | 5.35K |
| Target Price | $30.00 | Recom | None | Prev Close | $3.75 |
| Price | $3.86 | Change | 2.93% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$30.00
Mean price target
2. Current target
$3.86
Latest analyst target
3. DCF / Fair value
$-53.99
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.86
Low
$30.00
High
$30.00
Mean
$30.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-12-08 | main | Ascendiant Capital | Buy → Buy | $30 |
| 2025-09-22 | main | Ascendiant Capital | Buy → Buy | $38 |
| 2025-05-30 | main | Ascendiant Capital | Buy → Buy | $46 |
| 2025-04-21 | main | Ascendiant Capital | Buy → Buy | $50 |
| 2024-06-07 | main | Ascendiant Capital | Buy → Buy | $8 |
| 2023-03-31 | reit | HC Wainwright & Co. | — → Buy | $9 |
- What’s Driving The Rally In NDRA Stock Today? - Stocktwits ue, 14 Oct 2025 07
- 5 Stocks Under $5 to Watch Now: OBAI, NDRA, RIME, VTIX, OPEN - Barchart.com ue, 17 Feb 2026 17
- ENDRA (NASDAQ: NDRA) study supports TAEUS Liver as low-cost MRI-PDFF alternative - Stock Titan hu, 04 Dec 2025 08
- ENDRA Life Sciences stock soars after securing $4.9M for crypto strategy - Investing.com Mon, 13 Oct 2025 07
- ENDRA Life Sciences (NASDAQ: NDRA): A Dual-Engine Growth Story - openPR.com hu, 19 Feb 2026 19
- ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca - Business Wire Mon, 13 Oct 2025 07
- $5 Stocks Gaining Attention for 2026: EKSO, NDRA, ONTF, FLYE, RDZN See Why Inside - FinancialContent ue, 30 Dec 2025 08
- NDRA Stock Price, News & Analysis - Stock Titan Fri, 25 Apr 2025 00
- Endra’s Recent Surge: What’s Fueling the Rise? - StocksToTrade ue, 08 Jul 2025 07
- $5 Stocks: NDRA, IBRX, MOVE, RVLY Drawing Attention Watch Now! - The Chronicle-Journal Sun, 25 Jan 2026 08
- What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock - Yahoo Finance ue, 28 Jan 2025 08
- ENDRA Life Sciences stock falls after liver device study results - Investing.com Nigeria hu, 04 Dec 2025 08
- MAGA SmallCaps Watchlist: ROLR, SURG, IBRX, BNAI, NDRA - January 2026 Focus - marketscreener.com hu, 15 Jan 2026 08
- MAG 7 Undercard: $5 Stocks to Watch - NDRA, BSLK, WOLF, OCC, SNYR Poised for Action More Inside - openPR.com ue, 08 Jul 2025 07
- ENDRA Life Sciences (NASDAQ: NDRA) Gaining Attention as HYPE Token Surges See Why Now! FEED, SER, TRX, XHLD, BATL Inside - Barchart.com hu, 29 Jan 2026 22
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 60324 | — | — | Stock Award(Grant) at price 0.00 per share. | DIGIANDOMENICO ANTHONY | Director | — | 2026-01-21 00:00:00 | D |
| 1 | 75000 | — | — | Stock Award(Grant) at price 0.00 per share. | TOKMAN ALEXANDER Y | Chief Executive Officer | — | 2026-01-21 00:00:00 | D |
| 2 | 60324 | — | — | Stock Award(Grant) at price 0.00 per share. | HARSH MICHAEL JOHN | Director | — | 2026-01-21 00:00:00 | D |
| 3 | 60324 | — | — | Stock Award(Grant) at price 0.00 per share. | BASENESE LOUIS J. | Director | — | 2026-01-21 00:00:00 | D |
| 4 | 20000 | — | — | Stock Award(Grant) at price 0.00 per share. | JACROUX RICHARD | Chief Financial Officer | — | 2026-01-21 00:00:00 | D |
| 5 | 70822 | 500003 | — | Stock Award(Grant) at price 7.06 per share. | DIGIANDOMENICO ANTHONY | Director | — | 2025-10-10 00:00:00 | D |
| 6 | 5384 | — | — | Stock Award(Grant) at price 0.00 per share. | DIGIANDOMENICO ANTHONY | Director | — | 2025-06-11 00:00:00 | D |
| 7 | 5384 | — | — | Stock Award(Grant) at price 0.00 per share. | HARSH MICHAEL JOHN | Director | — | 2025-06-11 00:00:00 | D |
| 8 | 5384 | — | — | Stock Award(Grant) at price 0.00 per share. | BASENESE LOUIS J. | Director | — | 2025-06-11 00:00:00 | D |
| 9 | 3715 | 2052 | — | Purchase at price 0.55 per share. | UBS GROUP AG | Beneficial Owner of more than 10% of a Class of Security | — | 2024-08-27 00:00:00 | I |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -9.81M | -10.25M | -12.92M | -11.58M |
| TotalUnusualItems | -799.28K | 0.00 | 308.60K | |
| TotalUnusualItemsExcludingGoodwill | -799.28K | 0.00 | 308.60K | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -11.51M | -10.06M | -13.18M | -11.23M |
| ReconciledDepreciation | 206.17K | 275.45K | 234.26K | 224.41K |
| EBITDA | -10.61M | -10.25M | -12.92M | -11.27M |
| EBIT | -10.82M | -10.52M | -13.16M | -11.50M |
| NetInterestIncome | -7.32M | 0.00 | ||
| InterestExpense | 0.00 | |||
| NormalizedIncome | -10.71M | -10.06M | -13.18M | -11.54M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -11.51M | -10.06M | -13.18M | -11.23M |
| TotalExpenses | 10.82M | 10.52M | 13.16M | 11.50M |
| TotalOperatingIncomeAsReported | -10.82M | -10.52M | -13.16M | -11.50M |
| DilutedAverageShares | 202.11K | 3.64K | 1.65K | 1.17K |
| BasicAverageShares | 202.11K | 3.64K | 1.65K | 1.17K |
| DilutedEPS | -56.94 | -2.77K | -7.98K | -9.80K |
| BasicEPS | -56.94 | -2.77K | -7.98K | -9.80K |
| DilutedNIAvailtoComStockholders | -11.51M | -10.06M | -13.18M | -11.35M |
| NetIncomeCommonStockholders | -11.51M | -10.06M | -13.18M | -11.35M |
| OtherunderPreferredStockDividend | 0.00 | 121.07K | ||
| NetIncome | -11.51M | -10.06M | -13.18M | -11.23M |
| NetIncomeIncludingNoncontrollingInterests | -11.51M | -10.06M | -13.18M | -11.23M |
| NetIncomeContinuousOperations | -11.51M | -10.06M | -13.18M | -11.23M |
| TaxProvision | 0.00 | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -11.51M | -10.06M | -13.18M | -11.23M |
| OtherIncomeExpense | -690.80K | 460.49K | -21.53K | 267.06K |
| OtherNonOperatingIncomeExpenses | 108.48K | 460.49K | -21.53K | -41.55K |
| SpecialIncomeCharges | 0.00 | 308.60K | ||
| OtherSpecialCharges | -308.60K | |||
| GainOnSaleOfSecurity | -799.28K | |||
| NetNonOperatingInterestIncomeExpense | -7.32M | 0.00 | ||
| TotalOtherFinanceCost | 7.32M | |||
| InterestExpenseNonOperating | 0.00 | |||
| OperatingIncome | -10.82M | -10.52M | -13.16M | -11.50M |
| OperatingExpense | 10.82M | 10.52M | 13.16M | 11.50M |
| ResearchAndDevelopment | 3.19M | 5.00M | 6.55M | 5.48M |
| SellingGeneralAndAdministration | 7.63M | 5.52M | 6.60M | 6.02M |
| SellingAndMarketingExpense | 571.04K | 820.55K | 1.43M | 1.08M |
| GeneralAndAdministrativeExpense | 7.06M | 4.70M | 5.17M | 4.94M |
| OtherGandA | 7.06M | 4.70M | 5.17M | 4.94M |
| GrossProfit | 0.00 | |||
| TotalRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | 2022-12-31 | 2021-12-31 | ||
|---|---|---|---|---|
| PreferredSharesNumber | 141.00 | 141.00 | ||
| OrdinarySharesNumber | 536.91K | 5.94K | 1.81K | 1.26K |
| ShareIssued | 536.91K | 5.94K | 1.81K | 1.26K |
| TotalDebt | 584.42K | 394.40K | 546.63K | 678.96K |
| TangibleBookValue | 2.56M | 5.66M | 7.20M | 10.78M |
| InvestedCapital | 2.56M | 5.69M | 7.23M | 10.81M |
| WorkingCapital | 2.83M | 2.13M | 3.68M | 10.55M |
| NetTangibleAssets | 2.56M | 5.66M | 7.20M | 10.78M |
| CapitalLeaseObligations | 584.42K | 365.92K | 518.15K | 650.48K |
| CommonStockEquity | 2.56M | 5.66M | 7.20M | 10.78M |
| PreferredStockEquity | 1.00 | 1.00 | 1.00 | |
| TotalCapitalization | 2.56M | 5.66M | 7.20M | 10.81M |
| TotalEquityGrossMinorityInterest | 2.56M | 5.66M | 7.20M | 10.78M |
| StockholdersEquity | 2.56M | 5.66M | 7.20M | 10.78M |
| OtherEquityInterest | 5.23K | 6.07K | 13.86K | |
| RetainedEarnings | -103.44M | -91.93M | -81.87M | -68.69M |
| AdditionalPaidInCapital | 106.00M | 97.58M | 89.07M | 79.46M |
| CapitalStock | 53.00 | 2.00 | 318.00 | 213.00 |
| CommonStock | 53.00 | 1.00 | 317.00 | 212.00 |
| PreferredStock | 0.00 | 1.00 | 1.00 | 1.00 |
| TotalLiabilitiesNetMinorityInterest | 1.89M | 1.10M | 2.07M | 2.09M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 1.29M | 192.06K | 365.92K | 546.63K |
| DerivativeProductLiabilities | 799.28K | 0.00 | ||
| LongTermDebtAndCapitalLeaseObligation | 487.48K | 192.06K | 365.92K | 546.63K |
| LongTermCapitalLeaseObligation | 487.48K | 192.06K | 365.92K | 518.15K |
| LongTermDebt | 28.48K | |||
| CurrentLiabilities | 605.23K | 903.10K | 1.70M | 1.54M |
| CurrentDebtAndCapitalLeaseObligation | 96.94K | 202.34K | 180.71K | 132.33K |
| CurrentCapitalLeaseObligation | 96.94K | 173.86K | 152.23K | 132.33K |
| CurrentDebt | 28.48K | 28.48K | ||
| OtherCurrentBorrowings | 28.48K | 28.48K | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 5.75K | 41.27K | 689.49K | 401.79K |
| PayablesAndAccruedExpenses | 502.54K | 659.49K | 833.52K | 1.01M |
| CurrentAccruedExpenses | 232.86K | 299.08K | 219.56K | 218.59K |
| Payables | 269.68K | 360.40K | 613.96K | 791.05K |
| AccountsPayable | 269.68K | 360.40K | 613.96K | 791.05K |
| TotalAssets | 4.45M | 6.75M | 9.27M | 12.87M |
| TotalNonCurrentAssets | 1.02M | 3.72M | 3.89M | 780.53K |
| OtherNonCurrentAssets | 5.99K | 2.63M | 2.65M | 5.99K |
| NonCurrentPrepaidAssets | 365.42K | 626.61K | 502.58K | |
| NetPPE | 647.29K | 465.87K | 741.47K | 774.54K |
| AccumulatedDepreciation | -635.82K | -600.40K | -643.68K | -581.80K |
| GrossPPE | 1.28M | 1.07M | 1.39M | 1.36M |
| ConstructionInProgress | 125.15K | 125.15K | 140.62K | 107.68K |
| OtherProperties | 578.01K | 354.09K | 505.82K | 643.41K |
| Properties | 579.95K | 587.03K | 738.72K | 605.25K |
| CurrentAssets | 3.43M | 3.03M | 5.38M | 12.09M |
| PrepaidAssets | 204.19K | 198.91K | 490.30K | 1.35M |
| Inventory | 2.64M | 1.28M | ||
| RawMaterials | 1.28M | |||
| CashCashEquivalentsAndShortTermInvestments | 3.23M | 2.83M | 4.89M | 9.46M |
| CashAndCashEquivalents | 3.23M | 2.83M | 4.89M | 9.46M |
| CashFinancial | 3.23M | 2.83M | 4.89M | 9.46M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -7.42M | -9.58M | -12.97M | -11.17M |
| RepaymentOfDebt | -28.48K | |||
| IssuanceOfDebt | 0.00 | |||
| IssuanceOfCapitalStock | 1.15M | 6.48M | 8.40M | 10.62M |
| CapitalExpenditure | -16.00K | -33.88K | -202.58K | -45.00K |
| InterestPaidSupplementalData | 31.91K | 44.98K | 59.11K | 57.66K |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 | 0.00 |
| EndCashPosition | 3.23M | 2.83M | 4.89M | 9.46M |
| BeginningCashPosition | 2.83M | 4.89M | 9.46M | 7.23M |
| ChangesInCash | 395.57K | -2.06M | -4.57M | 2.23M |
| FinancingCashFlow | 7.81M | 7.52M | 8.40M | 13.40M |
| CashFlowFromContinuingFinancingActivities | 7.81M | 7.52M | 8.40M | 13.40M |
| NetOtherFinancingCharges | 1.00 | |||
| ProceedsFromStockOptionExercised | 6.69M | 1.03M | 0.00 | 2.79M |
| NetCommonStockIssuance | 1.15M | 6.48M | 8.40M | 10.62M |
| CommonStockIssuance | 1.15M | 6.48M | 8.40M | 10.62M |
| NetIssuancePaymentsOfDebt | -28.48K | 0.00 | ||
| NetShortTermDebtIssuance | -28.48K | |||
| ShortTermDebtPayments | -28.48K | |||
| NetLongTermDebtIssuance | -28.48K | 0.00 | ||
| LongTermDebtPayments | -28.48K | |||
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | -12.80K | -24.72K | -202.58K | -45.00K |
| CashFlowFromContinuingInvestingActivities | -12.80K | -24.72K | -202.58K | -45.00K |
| NetPPEPurchaseAndSale | -12.80K | -24.72K | -202.58K | -45.00K |
| SaleOfPPE | 3.20K | 9.16K | 0.00 | |
| PurchaseOfPPE | -16.00K | -33.88K | -202.58K | -45.00K |
| OperatingCashFlow | -7.40M | -9.55M | -12.77M | -11.12M |
| CashFlowFromContinuingOperatingActivities | -7.40M | -9.55M | -12.77M | -11.12M |
| ChangeInWorkingCapital | 134.08K | -923.32K | -1.03M | -1.26M |
| ChangeInOtherCurrentLiabilities | -158.70K | -152.23K | -132.33K | -100.34K |
| ChangeInOtherCurrentAssets | 0.00 | |||
| ChangeInPayablesAndAccruedExpense | -198.87K | -822.26K | 111.58K | 491.10K |
| ChangeInPrepaidAssets | 255.91K | 167.36K | 355.13K | -957.20K |
| ChangeInInventory | 235.73K | -116.19K | -1.36M | -694.96K |
| OtherNonCashItems | -1.00 | |||
| StockBasedCompensation | 571.92K | 996.43K | 1.20M | 1.44M |
| ProvisionandWriteOffofAssets | 2.39M | 138.04K | 0.00 | |
| AssetImpairmentCharge | 8.81K | 24.87K | 1.39K | 9.87K |
| DepreciationAmortizationDepletion | 206.17K | 275.45K | 234.26K | 224.41K |
| DepreciationAndAmortization | 206.17K | 275.45K | 234.26K | 224.41K |
| Depreciation | 206.17K | 275.45K | 234.26K | 224.41K |
| OperatingGainsLosses | 799.28K | -308.60K | ||
| GainLossOnInvestmentSecurities | 799.28K | |||
| NetIncomeFromContinuingOperations | -11.51M | -10.06M | -13.18M | -11.23M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for NDRA
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|